- PERSISTENCE HANDOUT - ESALOMI COMPLAINT - AUG2022-047124616032
- An Overview of Telehealth and Controlled Substance Prescribing in Florida
- RUAN-11th Cir. OPINION
- RUAN-11th Cir. OPINION~1
- DOJ MEMO - 2013 - MARIJUANA-3052013829132756857467(2)
- FSMB-2017-Opioid Guidelines As Adopted April 2017_FINAL
- FSMB-THC-BRD_RPT_16-2_Marijuana_Model_Guidelines
- 2006;9;1-40-ASIPP
- KAPOOR-VACATE CSA CONVICTIONS-CRITICAL-09519680541
- PlotThickens-HANDOUT-Opioid-Litigation-Tracker-20210503
- DEAPolicyStatements-Summary2007
- RUAN-SUPREMECOURTOPINION-20-1410_1an2~1
- HIGHWAY61-MAT-telemedicine-dea-guidance
- RUAN-SUPREMECOURTOPINION-20-1410_1an2
- 2002_grpol_Opioid_Addiction_Treatment
- 2004_grpol_Controlled_Substances-1
- 2004_grpol_Controlled_Substances
- CDC-2022-02802(2)
- HIGHWAY61-(DEA-DC-022)(DEA068) DEA SAMHSA buprenorphine telemedicine (Final) +Esign(8)